ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $644,000 | +11.4% | 48,468 | +30.6% | 1.37% | +1283.8% |
| Q4 2018 | $578,000 | +18.4% | 37,111 | +49.3% | 0.10% | +98.0% |
| Q3 2018 | $488,000 | -26.6% | 24,849 | +7.2% | 0.05% | -91.5% |
| Q2 2018 | $665,000 | -35.6% | 23,175 | -46.9% | 0.59% | -34.3% |
| Q1 2018 | $1,032,000 | +4.1% | 43,653 | -5.5% | 0.90% | -28.1% |
| Q4 2017 | $991,000 | -30.2% | 46,214 | -23.0% | 1.24% | +551.3% |
| Q3 2017 | $1,419,000 | +20.1% | 60,003 | 0.0% | 0.19% | +8.5% |
| Q2 2017 | $1,182,000 | +12.6% | 60,003 | +20.0% | 0.18% | -5.9% |
| Q1 2017 | $1,050,000 | +23.5% | 50,019 | +10.6% | 0.19% | -26.4% |
| Q4 2016 | $850,000 | +68.3% | 45,209 | +87.0% | 0.25% | +4.1% |
| Q3 2016 | $505,000 | -6.3% | 24,177 | +14.4% | 0.24% | -39.0% |
| Q2 2016 | $539,000 | +32.1% | 21,130 | +37.1% | 0.40% | -28.8% |
| Q1 2016 | $408,000 | – | 15,412 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
| ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
| SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
| SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
| Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
| ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
| Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
| Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |